SPACA6 and breast cancer: By analyzing the correlation between the clinical-pathological characteristics of these two patient groups and the expression levels of SPACA6P-AS, we found a significant association between increased SPACA6P-AS expression and the PAM50 subtypes of BC as well as a history of receiving radiotherapy (Table 1, Fig. 2).